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Polarized actin and VE-cadherin dynamics regulate
junctional remodelling and cell migration during
sprouting angiogenesis
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VEGFR-2/Notch signalling regulates angiogenesis in part by driving the remodelling of
endothelial cell junctions and by inducing cell migration. Here, we show that VEGF-induced
polarized cell elongation increases cell perimeter and decreases the relative VE-cadherin
concentration at junctions, triggering polarized formation of actin-driven junction-associated
intermittent lamellipodia (JAIL) under control of the WASP/WAVE/ARP2/3 complex. JAIL
allow formation of new VE-cadherin adhesion sites that are critical for cell migration and
monolayer integrity. Whereas at the leading edge of the cell, large JAIL drive cell migration
with supportive contraction, lateral junctions show small JAIL that allow relative cell move-
ment. VEGFR-2 activation initiates cell elongation through dephosphorylation of junctional
myosin light chain II, which leads to a local loss of tension to induce JAIL-mediated junctional
remodelling. These events require both microtubules and polarized Rac activity. Together, we
propose a model where polarized JAIL formation drives directed cell migration and junctional
remodelling during sprouting angiogenesis.
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The formation of new blood vessels from a pre-existingvascular network, angiogenesis, involves the participationof endothelial cells (ECs), stromal cells (like ﬁbroblasts),
pericytes and the control of extracellular matrix turnover, all of
which are coordinated by many angiogenic and angiostatic fac-
tors. Angiogenesis is frequently initiated by a gradient of vascular
endothelial growth factor (VEGF) that leads to the induction of
endothelial-derived tip cells, which extend ﬁlopodia and lead
sprouts during their extension into VEGF-expressing tissues1.
Proliferating stalk cells allow vessel growth to follow migrating tip
cells1. Tip and stalk cells are thought to interconvert dynamically,
leading to changes in the leading cell position2. Cell migration
and positional changes by angiogenic ECs require closely coor-
dinated interactions of cell junctions that critically depend on the
dynamics of vascular endothelial cadherin (VE-cadherin)3–5. In
particular, a moderate decrease in VE-cadherin expression
enhances angiogenic sprouting in vitro6 and in the murine retina
in vivo, as demonstrated by inducible inactivation of the cadherin
5 (Cdh5) gene encoding VE-cadherin3. VE-cadherin is also
essential for proper vessel growth and lumen formation, and,
accordingly, lumen development is disrupted in Cdh5 knockout
embryos7. Moreover, VE-cadherin was shown to suppress
VEGFR2-Rac1-dependent vessel sprouting6. These data indicate
that an appropriate VE-cadherin concentration at cell junctions is
critical for proper angiogenesis.
Despite these insights, increasing vessel size and lumen for-
mation by stalk cells increases the number of cell contacts by
which a particular cell connects to several other cells, including
the tip cell/stalk cell interaction, e.g., during interconversion. This
important aspect becomes even more important, as stalk cells not
only move forward but can also migrate backwards in an existing
vessel-like structure2, a fact that requires, apart from individually
regulated junctions, a reversal of cell polarity. A structure that
gave some insight into this aspect was described in a recent cell
culture study, demonstrating that local reduction of VE-cadherin
at particular endothelial junction sites initiates the formation of
actin-driven plasma membrane protrusions. Due to their tran-
sient, spatiotemporally restricted and highly dynamic features,
these structures were termed junction-associated intermittent
lamellipodia (JAIL)8. JAIL, in turn, induce new VE-cadherin
adhesion sites and thereby drive VE-cadherin and actin dynamics
interdependently, resulting in a coupling of VE-cadherin and
actin dynamics in migrating ECs. Furthermore, JAIL are con-
trolled by WAVE/WASP/ARP2/3 complex and ensure endothe-
lial integrity8, which is consistent with WAVE/WASP-mediated
docking structure formation during lymphocyte transmigration
and maintained barrier function9. In addition, a recent work
demonstrated differential VE-cadherin patterning characterised
by “junctional cortex” protrusions, which can be induced by the
pro-angiogenic factor VEGF or the inhibition of Notch signal-
ling4. On the basis of the results presented here, we were able to
develop a model of cell junction dynamics for VEGFR2/Notch-
mediated polar cell migration during angiogenesis that includes
contraction/relaxation mechanisms and interdependent dynamics
of microtubules, VE-cadherin and actin.
Results
Cell elongation reduces relative VE-cadherin concentration.
VE-cadherin and actin dynamics at EC junctions are upregulated
in cells with increased cell junction length via JAIL formation,
which is activated by a reduced relative VE-cadherin concentra-
tion (Rel-VEcad-C) at extended cell junctions, although the total
amount of VE-cadherin remains unchanged as demonstrated in
human umbilical vein endothelial cell (HUVEC) cultures8. Sug-
gesting that a similar mechanism plays a role during angiogenesis,
we found in VE-cadherin-labelled P6 mice retinas an increased
EC junction length at the angiogenic front compared with those
in the vein or in the perivenous capillaries (Fig. 1a, b). Cell
elongation caused a decrease in Rel-VEcad-C of 22% compared
with in EC of the central veins and of 14.5% compared with the
mature perivenous EC (capillary plexus) (Fig. 1a, c). The product
of the mean Rel-VEcad-C and the corresponding mean cell
perimeter conﬁrmed that the total VE-cadherin content per cell
was largely constant (Fig. 1d). Thus, we hypothesised that the
decrease in Rel-VEcad-C could promote cell junction dynamics
and cell motility in angiogenesis in vivo by JAIL formation.
JAIL drive junction dynamics in sheet migration. After
scratching a wound in conﬂuent HUVEC cultures, classical
lamellipodia appeared on the front cells (leaders), followed by
directed cell migration as described previously10. Most followers
responded with shape change, mainly by cell elongation and
directed cell migration. A number of cells, however, transiently
changed direction and moved backwards or appeared to be sta-
tionary. The overall monolayer integrity was conserved
throughout the wound closure (Supplementary Movie 1).
Immune-stained endogenous VE-cadherin and actin in scratched
cultures (5 h after scratch) displayed disassembled junction-
associated actin ﬁlaments (JAAF) and stress ﬁbre formation in EC
at the front area, whereas centred cells largely retained JAAF
(Fig. 2a). Small intercellular gaps appeared occasionally, pre-
ferentially between leader cells, which were quickly closed by JAIL
(Fig. 2a), a process that was reported in previous studies8,11,12.
The increased cell perimeter (up to 156%) of front cells (Fig. 2b)
was accompanied by a decrease in Rel-VEcad-C down to 73.8%
(200 µm from the wound edge) (Fig. 2c). Furthermore, elongated
cells displayed an increase in JAIL size and number (Fig. 2d, e),
with large JAIL appearing at the cell poles while small JAIL were
characteristic for the lateral junctions (Fig. 2f).
To closely follow JAIL-mediated cell junction dynamics, VE-
cadherin-EGFP or VE-cadherin-mCherry and EGFP-p20, a
ﬂuorescence-tagged subdomain of the ARP2/3 complex13, were
co-expressed. Live-cell imaging of migrating cells conﬁrmed
constitutive VE-cadherin dynamics with formation of linear and
interrupted VE-cadherin intermediates (Supplementary Movie 2).
Importantly, VE-cadherin plaques appeared transiently at cell
junctions (Supplementary Movie 2). These plaques developed
after actin-driven and ARP2/3 complex-controlled protrusions
(JAIL) that formed at sites of reduced Rel-VEcad-C (e.g., as an
interrupted pattern). The interrupted VE-cadherin pattern at the
cell poles of elongated cells accompanied large JAIL, whereas the
linear VE-cadherin pattern at lateral junctions were associated
with small JAIL only (Supplementary Movie 3). Since actin-
driven JAIL overlap the corresponding plasma membrane of the
neighbouring cell, forming VE-cadherin adhesion that appeared
as VE-cadherin plaques (Supplementary Movie 3). The dissocia-
tion of branched actin ﬁlaments and the ARP2/3 complex (EGFP-
p20) correlated with termination of JAIL formation. Subse-
quently, the VE-cadherin plaques clustered during JAIL retrac-
tion and integrated into the cell contacts (Supplementary
Movie 3,4). This process iterated until high levels of VE-
cadherin concentration were attained and JAIL formation was
blocked.
To evaluate the impact of VE-cadherin concentration on
junction dynamics, VE-cadherin-EGFP was overexpressed in EC
cultures (Fig. 2g) that were subjected to a scratch assay (Fig. 2h).
As a result, JAIL formation, migration velocity, cell elongation
and cell perimeter expansion were blocked (Fig. 2i–l; Supple-
mentary Fig. 1a). However, the inhibitory effect was signiﬁcantly
less pronounced for the leader cells and the ﬁrst cell rows (0–200
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µm) (Fig. 2k, l) possibly because lamellipodia-mediated cell
elongation at the cell junction-free side occurred in a VE-
cadherin-independent manner. Since Rac activation is critical in
lamellipodia formation14, we applied the Rac inhibitor ETH1864,
which nearly totally blocked JAIL formation, cell elongation, and
sheet migration (Fig. 2m–o; Supplementary Fig. 1b). Thus, we
propose that the Rel-VEcad-C and Rac-dependent polarized JAIL
formation, together with contractile force development15,16, allow
directed cell migration while maintaining junction integrity.
Polarized VE-cadherin and actin patterns in angiogenesis.
Directed cell migration in angiogenesis requires cell polarisation
and subcellular regulation of cell junctions. Immune staining of
VE-cadherin in the developing retinas of P6 LifeAct-EGFP
transgenic mice17 revealed VE-cadherin and actin plaque-like
structures at the cell junctions (Fig. 3a). Structured illumination
microscopy (SIM) disclosed a polarized distribution of both VE-
cadherin and actin in tip and stalk cells (Fig. 3b), with ﬁlopodia
appearing at tip cell fronts (Fig. 3b, area 1). The cell poles between
tip and stalk cells or between stalk cells displayed an interrupted
VE-cadherin pattern or VE-cadherin plaques, whereas the lateral
junctions were characterised by a linear VE-cadherin pattern with
occasional interruptions or small VE-cadherin plaques (Fig. 3b,
areas 2, 3). Importantly, JAIL were visible at cell poles and at the
lateral junctions (Fig. 3b). In addition, in developing yolk sac
vasculature, we found a number of junction-localised VE-cad-
herin plaques indicative of JAIL formation, whereas in the adult
vein, few VE-cadherin plaques were observed (Supplementary
Fig. 2). Furthermore, in developing vessels (p7) of rat retinas, we
found a prominent ARP2/3 complex signal identiﬁed by anti-
ARPC2 labelling that appeared at the endothelial cell poles
(Fig. 3c), suggesting an ARP2/3 complex-mediated JAIL forma-
tion at this site. The overall morphology is comparable to the
morphology observed in vitro (Fig. 2a), and thus supports the
concept of polarized and iterative JAIL-mediated cell junction
dynamics in angiogenesis in vivo (Fig. 3d).
VEGF induces EC elongation and migration. We next investi-
gated whether the elongation-mediated decrease in the Rel-
VEcad-C increases the VE-cadherin and actin dynamics during
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Fig. 1Migrating front ECs in developing retinas demonstrate an increased perimeter and a reduced Rel-VEcad-C. a Representative heat-map images of VE-
cadherin-labelled ECs in front and centre areas of whole-mounted P6 mouse retinas. Area 1 and Area 2 (scale bar: 40 µm), depicted as indicated, display
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angiogenesis. VEGF application (50 ng ml−1) to conﬂuent (>105
cells cm−2) HUVEC cultures gradually induced cell elongation in
a subpopulation of the cells (Fig. 4a, b; Supplementary Movie 5).
Using paired experiments, we demonstrated a relationship
between cell elongation and migration activity. VEGF treatment
increased cell migration after 24 to 30 h, when cells were
elongated compared with the migration activity within the ﬁrst 6
h (Fig. 4c). Furthermore, polarized cell migration was char-
acterised by an increase in the Euclidean distance by 184%, and
the Accumulated distance (the sum of all zig-zag movements by
the cells) was increased by 119% (Fig. 4d; Supplementary Fig. 3a).
By immune labelling, we also demonstrated an inverse
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relationship between the VEGF-induced increase in cell perimeter
(153%) due to cell elongation and the decrease in the Rel-VEcad-
C (down to 81%) within 24 h (Fig. 4e–g). In contrast, the total
amount of VE-cadherin remained largely unchanged (Supple-
mentary Fig. 3b, c). Consistent with the heterogeneous cell shape
change after VEGF application, only a fraction of the cells dis-
played high VEGFR2 expression (Fig. 4h, i). In particular, the
elongated cells still displayed a high level of VEGFR2 expression
after VEGF stimulation, but the remaining polygonal cells did not
(Fig. 4h, j). In addition, downregulation of the VEGFR2 by siRNA
(Fig. 4k) totally blocked VEGF-induced cell elongation, whereas
knockdown of neuropillin1 (Nrp1), a co-activator of the receptor
tyrosine kinase signalling of VEGFR218, had only a moderate
effect (Fig. 4i, m; Supplementary Movie 6). Thus, the VEGF-
induced cell elongation is regulated by VEGFR2 signalling with a
minor inﬂuence of Nrp1. To evaluate whether VEGFR2-induced
cell elongation and polarized migration are also dependent on a
decrease in Rel-VEcad-C, VE-cadherin was overexpressed in
HUVEC cultures (Supplementary Fig. 3d). Indeed, under these
conditions, VEGF-induced cell elongation was largely blocked,
and consequently, overall cell velocity was reduced (Fig. 4n;
Supplementary Movie 7), although VEGFR2 expression remained
unchanged (Fig. 4o). Thus, we conclude that VEGF-induced cell
elongation requires balanced Rel-VEcad-C levels at the cell
junctions to activate JAIL-mediated cell motility.
Loss of contractility triggers VE-cadherin dynamics. VEGF-
activated cell junction dynamics was evaluated in VE-cadherin-
EGFP-expressing conﬂuent HUVEC cultures by spinning disc
microscopy (SDM). Time-lapse recordings revealed increased
VE-cadherin dynamics within 10 to 20 min after VEGF applica-
tion in a subset of cells (Supplementary Movie 8). In particular,
VE-cadherin remodelling accompanied the appearance of spa-
tiotemporally restricted invaginations that increased in number
and length within 1 h and preferentially appeared in cells with
high VEGFR2 expression (Fig. 5a, b, e, f). SIM of VEGF-treated
HUVECs revealed a reduced co-distribution of VE-cadherin and
actin at cell junctions and invaginations as well as a moderate
amount of stress ﬁbre formation (Fig. 5b). Actin-driven junction
dynamics were upregulated shortly after VEGF application.
Furthermore, a few vesicle-like structures were released from the
junctions, resembling endocytic processes (Supplementary
Movie 8). However, the VE-cadherin-positive vesicle-like struc-
tures that were taken up were largely negative for the endosome
antigen 1 (EEA1) and Rab5 (Supplementary Fig. 4). For this
reason, no further investigations were carried out, since we
expected this small number of endocytic vesicles to play only a
minor role in the phenomena observed here.
We next investigated whether myosin light chain (MLC)
phosphorylation, which controls actin/myosin II-mediated ten-
sion development in endothelium, might play a role in actin and
VE-cadherin dynamics19,20. Immune labelling of conﬂuent cell
cultures and developing retinas in vivo with a speciﬁc phospho-
(ser19)-myosin II light chain antibody (P-ser-MII-LC) produced
a clear signal at cell junctions of centre vein ECs in vivo (Fig. 5c)
and in conﬂuent HUVEC cultures (Fig. 5d). The signal was
largely negative at front EC junctions in the retina (Fig. 5c) and at
the junctions of HUVECs within 5 min after VEGF application
(Fig. 5d). This phenomenon was accompanied by a partially
(local) dissociated JAAF and stress ﬁbre formation that were
positive for P-ser-MII-LC in HUVEC cultures, which is in
agreement with the appearance of wave-like junction remodelling
(Fig. 5d). In addition, a complete loss of P-ser-MII-LC was
evident 1 h after application of the ROCK inhibitor Y27632,
which blocks actin/myosin II-mediated contraction21,22 (Fig. 5d).
VE-cadherin immune labelling as well as live-cell imaging
revealed a dramatic increase in the size and number of
invaginations as well as the appearance of curved VE-cadherin
junctions after Y27632 application (Fig. 5g, h; Supplementary
Movie 9; Supplementary Fig. 5a, b), Furthermore, an increase in
junction length and a decrease in Rel-VEcad-C (Fig. 5i, j;
Supplementary Movie 9) accompanied cell migration and cell
elongation within 18 h (Fig. 5k, l; Supplementary Fig. 5c). A
synergistic effect of Y27632 and VEGF was evident after
combined application (Fig. 5k, l). Thus, we propose a
relaxation-dependent subcellular activation of actin dynamics
that initiates cell elongation and polarisation and increases
migration activity.
Microtubule dynamics is key in polarized cell elongation. Cell
polarisation has been shown to involve microtubules (MT)
activity23,24. Labelling of MT in HUVECs documented a single
MT organization centre (MTOC) from which MT distributed
throughout the cells; a few MT were enriched at cell junctions,
where they paralleled the JAAF ﬁlaments and VE-cadherin
(Fig. 6a). Twenty-four hours after, VEGF application, the MT
were distributed along polarized stress ﬁbres, and this was
accompanied by an interrupted VE-cadherin pattern at the cell
pole (Fig. 6a). Analysis of MT dynamics was performed in β5-
tubulin-EGFP-expressing HUVEC cultures by SDM. The addi-
tion of VEGF resulted in increased MT dynamics, especially in
the cell’s half containing the MTOC. A progressive increase in
Fig. 2 JAIL formation and cell migration are blocked by Rac inhibition and VE-cadherin overexpression in scratch assay. a–f HUVECs were scratched,
allowed to grow for 5 h, and labelled for VE-cadherin and Phalloidin-TRITC. a Overviews of the migrating front (left upper) and centre area (left lower).
(Area 1) interrupted VE-cadherin that co-localise with ﬁlopodia-like actin ﬁlaments (arrows). (Area 2) Large JAIL (arrowheads) at cell pole. (Area 3) small
JAIL (arrowheads) at lateral junctions. (Area 4) Polygonal cells in the centre area. Scale bars represent 60 µm and 15 µm in the overview and cropped
images respectively. b, c Comparison of cell perimeter and Rel-VEcad-C in front and centre ECs. Quantiﬁcation of (d) JAIL number and (e) JAIL size in front
(n= 115 cells) and centre cells (n= 186 cells). f JAIL size at cell poles and lateral junctions in front ECs (n= 115 cells). P value was determined by unpaired
student’s t test. g Western blot demonstrates VE-cadherin-EGFP overexpression by a factor of about 4 using VE-cadherin (green) and EGFP (red)
antibodies. h VE-cadherin was immune labelled in VE-cadherin-EGFP-overexpressing and EGFP-expressing cells; nuclei were stained blue with DAPI. Scale
bar: 100 µm. i Representative images of VE-cadherin-EGFP-overexpressing and EGFP-expressing cells in a scratch assay. Red dotted lines indicate wound
margins. Scale bar: 150 µm. j Quantiﬁcation of migration velocity 18.5 h after the scratch (n= 83 and 85 cells, respectively, unpaired student’s t test). k, l
Quantiﬁcation of elongation factor and cell perimeter using CBT based on immunoﬂuorescence images [n= 176 and 205 cells for VE-cadherin-EGFP-
transfected HUVECs, and n= 139 and 165 cells for EGFP-expressing HUVECs at distance (≈ 0–200) and (≈ 200–400) in the scratch area, two-way
ANOVA]. m Time-lapse series of HUVECs expressing LifeAct-EGFP after scratching. (Left) Overview image (scale bar: 50 µm) indicates the scratch front
(dotted line) and the white box represents the cropped area. JAIL formation (arrowheads) in the same cells was blocked by EHT1864, while ﬁlopodia still
developed (arrows). Time scale: hh:mm, scale bar: 10 µm. Live-cell imaging-based analyses of (n) cell perimeter (front to 200 µm, n= 50 cells) and (o)
wound closure (n= 3) (two-way ANOVA). Representative results from three independent experiments were shown. Error bars represent± SEM. VE-cad-
EGFP VE-cadherin-EGFP
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02373-8 ARTICLE
NATURE COMMUNICATIONS |8:  2210 |DOI: 10.1038/s41467-017-02373-8 |www.nature.com/naturecommunications 5
polarized MT dynamics ultimately led to cell elongation and
increased migration (Fig. 6a, Supplementary Movie 10). MT
depolymerisation by 50 ng ml−1 nocodazole caused a loss of cell
polarity, elongation, and migration and led to rounding of the
cells within 2 h (Supplementary Movie 10), while VE-cadherin
was still localised at the junction after 4 h (Fig. 6b). Furthermore,
rounded cells still displayed protrusions that appeared in a ran-
domised manner (Supplementary Movie 10). Similar results were
obtained when HUVEC cultures were treated with nocodazole
prior to VEGF application (Fig. 6c–e). The results are consistent
with the nocodazole-mediated inhibition of shear stress-induced
cell elongation25. These data demonstrate that MT activity is
indispensable for initiation and maintenance of VEGF-induced
endothelial shape change and for polarized cell dynamics but not
for maintenance of VE-cadherin-mediated cell adhesion and
dynamics.
Cell junction dynamics in VEGF-induced elongated cells. SDM
of HUVECs that moderately express VE-cadherin-EGFP, LifeAct-
EGFP or EGFP-p20 was performed to investigate VEGF-induced
junction remodelling. Under control conditions, VE-cadherin-
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EGFP displayed a moderate but constitutive formation of plaque-
like structures that correspond to JAIL (Fig. 7a). VEGF-induced
cell elongation established a planar polarity with two short cell
poles, one of which represents the leading and the other the
trailing end; both displayed an interrupted VE-cadherin–EGFP
pattern that alternates with VE-cadherin plaque formation
induced by large JAIL. A faint, linear VE-cadherin-EGFP pattern
developed at lateral junctions with the appearance of much
smaller VE-cadherin plaques (Fig. 7a; Supplementary Fig. 6a).
Immune labelling revealed that only 43% of the elongated cells
displayed an interrupted VE-cadherin pattern at the cell poles at a
given time point (Supplementary Fig. 6b), which is consistent
with rapid constitutive VE-cadherin dynamics and disintegration
of the cell junctions during cell migration.
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Actin dynamics was studied in LifeAct-EGFP-expressing
conﬂuent HUVEC cultures. Application of VEGF induced a
polarized, progressive cell elongation in some cells that constantly
migrated in one direction and displayed large JAIL and ﬁlopodia
formation, whereas polygonal cells displayed slow and rando-
mised movement (Fig. 7b–e; Supplementary Movie 11). Forma-
tion and retraction of ﬁlopodia seemed to occur spontaneously at
cell poles (Supplementary Movie 11), whereas JAIL was followed
by formation of new VE-cadherin adhesion sites (Supplementary
Movie 3). Filopodia rarely developed at the lateral junctions of
elongated cells, whereas small JAIL appeared regularly, probably
contributing to the relative cell migration. Furthermore, the local
loss of JAAF accompanied polarized migration activity at the side
of the cells where the stress ﬁbres appeared, a result consistent
with MT distribution and dynamics.
Since stress ﬁbres are contractile structures in endothelium20,26,
we proposed that newly formed VE-cadherin adhesion sites at the
leading end might function as anchors for migrating cells to be
pulled by stress ﬁbre contraction. This process was indeed visible
during formation of large VE-cadherin adhesion plaques at the
cell poles during polarized cell migration (Fig. 7a; Supplementary
Fig. 6a), the data that are consistent with the recently reported
development of contractile forces at endothelial junctions during
sheet migration15. In contrast, polygonal cells still retained the
JAAF band and did not develop stress ﬁbres or show increased
actin dynamics, irrespective of the presence of VEGF (Fig. 7b;
Supplementary Movie 11). Polarized JAIL dynamics were further
studied by live-cell imaging using EGFP-p20-labelled HUVEC
cultures, which conﬁrmed the high activity and formation of large
JAIL at the leading end (Fig. 7f; Supplementary Movie 12). These
JAIL were about 2.5 times larger than those at the lateral junctions
(Fig. 7g). The data document that directed migrating elongated
cells, but not randomly migrating polygonal cells, display a high
degree of polarized junction dynamics and the establishment of a
polarized VE-cadherin, MT, and actin patterning suggests that cell
elongation is a key parameter in cell motility.
Rac1 activation triggers cell elongation and JAIL formation.
RhoGTPases Rac are critical in directed cell migration14, and
VEGFR2 activation targets the small GTPase Rac127,28. Our
observation of VEGF-induced polarized actin dynamics at EC
junctions led us to suggest a role for Rac in this process.
Expression of a FRET-based Rac sensor29,30 in conﬂuent
HUVECs revealed randomised Rac activity at cell junctions in
control cells, at sites of small actin-driven JAIL. In con-
trast, VEGF-treated elongated cells, embedded in a conﬂuent cell
layer, exhibited elevated levels of Rac1 activity at the leading end
where large JAIL appeared (Fig. 8a–c; Supplementary Movie 13).
A small amount of spatiotemporally restricted elevation of
Rac appeared at lateral junctions, consistent with the presence of
small JAIL at this site (Fig. 8a–c; Supplementary Movie 13).
Application of the Rac1 inhibitor EHT1864 or expression of
the dominant negative N17Rac1 blocked VEGF-induced cell
elongation and migration (Fig. 8d–f; Supplementary Fig. 7a, b;
Supplementary Movie 14). Interestingly, application of EHT1864
to LifeAct-EGFP-expressing HUVEC cultures inhibited JAIL but
not ﬁlopodia formation (Supplementary Fig. 7c; Supplementary
Movie 14), suggesting that ﬁlopodia were not required to drive
cell elongation. In line with this, stimulation of Rac activity via
application of 10 µM Sew2871, a spingosine-1-phosphate receptor
(S1P-R) activator, signiﬁcantly increased JAIL formation, and a
synergistic effect of Sew2871 and VEGF on cell elongation and
migration velocity was observed (Fig. 8g–j; Supplementary Fig. 7d;
Supplementary Movie 15).
ARP2/3 complex controls JAIL formation in angiogenesis. The
data presented thus far strongly suggest that polarized cell contact
dynamics involving loss of contraction, MTs, ARP2/3 complex,
and actin and VE-cadherin dynamics provide the mechanistic
preconditions for cell elongation and directional cell migration in
angiogenesis. For further evaluation, we used an in vitro angio-
genesis model utilising HUVEC-covered micro-carrier beads
embedded in ﬁbrin gel31,32. Phase-contrast time-lapse recordings
revealed endothelial outgrowth from the bead surface, with a tip
cell-like morphology and long ﬁlopodia and lumen formation
(Supplementary Movie 16, left panel). Leader cells and followers
interconverted at the leading position (Supplementary Movie 16,
left panel), as described previously2. Furthermore, 4D time-lapse
recordings of EGFP-p20-expressing HUVECs demonstrated
EGFP-p20-positive ﬁlopodia-like structures and lamellipodia at
the front end of migrating tip cells (Fig. 9a), which is consistent
with the demonstration that lamellipodia as well as ﬁlopodia can
guide tip cells33. To better visualise the junction activity in tube-
forming sprouts (Supplementary Movie 16, right panel), we
examined a z-plane that was close to the tube wall (Supplemen-
tary Movie 17, 18) that allowed us to follow the junction
dynamics at cell poles and lateral junctions. Both tip cell/stalk cell
junctions and stalk cell/stalk cell junctions displayed high ARP2/3
activity at the cell poles, forming large JAIL as veriﬁed by the
curved, overlapping EGFP-p20-positive structures, whereas the
lateral junctions displayed less EGFP-p20 activity, indicative of
small JAIL (Fig. 9b, c; Supplementary Movie 17, 18). JAIL were
Fig. 4 VEGFR2 and VE-cadherin expression control VEGF-induced EC elongation and migration. Conﬂuent HUVECs were treated with 50 ng ml−1 VEGF or
PBS. a Time-lapse images show cell elongation (arrows) in a subpopulation of HUVECs (Scale bar: 30 µm). b PhaCoB Cell Tracker analysis of cell
elongation 5 h after VEGF (n= 3070 cells, one-way ANOVA). c VEGF-dependent cell velocity in the ﬁrst 6 h (n= 71 cells) and after 24 h (n= 77 cells). d
Elongated cells displayed increased 'Euclidean distance' (ED) and 'Accumulated distance' (AD) comparison to polygonal cells in the same VEGF-treated
culture (n= 30 cells from t= 24–30 h, two-way ANOVA). e Anti-VE-cadherin-labelled HUVEC cultures. Rel-VEcad-C was decreased in a subpopulation of
elongated cells (arrow) but not in polygonal cells (arrowhead) (scale bar: 20 µm). Quantiﬁcation of (f) cell perimeter and (g) Rel-VEcad-C based on
immunoﬂuorescent labelling using the CBT. h HUVECs were stained with VE-cadherin (green) and VEGFR2 (red) (scale bar: 20 µm). i Quantitative
distribution of the relative VEGFR2 intensity under PBS (n= 59 cells). j Correlation of relative VEGFR2 intensity with elongation factor in VEGF-treated
HUVEC; n= 146 cells; R= correlation coefﬁcient. kWestern blot demonstrates downregulation of VEGFR2 and Nrp1 by the respective siRNAs but not non-
targeting siRNA (siNt). l VEGFR2 downregulation totally blocked VEGF-induced cell elongation as determined by PhaCoB Cell Tracker, whereas Nrp1
downregulation had only a minor effect (n≈ 3500/time point), compare Supplementary Movie 6. m A small but statistically signiﬁcant decrease in the
perimeter in Nrp1-downregulated cells quantiﬁed based on VE-cadherin-labelling using CBT (n= 100 cells). n (left) VE-cadherin-EGFP overexpression
blocked the VEGF-induced elongation as analysed by PhaCoB Cell Tracker (n≈ 1100 cells/time point). (right) Determination migration velocity of VE-
cadherin-EGFP (n= 100 cells) and EGFP (n= 101 cells) overexpressing HUVEC in the presence of VEGF for 24 h. Compare supplementary movie 7. o (left)
Western blot of VEGFR2 expression after VE-cadherin-EGFP overexpression. (right) Quantiﬁcation of VEGFR2 expression in VE-cadherin overexpressing
cells (n= 3). α-tubulin served as an internal loading control. Unpaired student’s t test was used to analyse the signiﬁcance difference for experiment c, f, g,
m, n, o. Error bars represent± SEM. Representative results from three independent experiments are shown
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about 3.5 times larger at cell poles than at lateral junctions
(Fig. 9d). The application of the ARP2/3 complex inhibitor
CK666 or the Rac inhibitor EHT 1864 blocked JAIL formation
(Fig. 9c) and reduced the migration velocity (measured by nuclear
movement) in the 4D angiogenesis assay to about 25% of control
values (Fig. 9e). We also observed stalk cell mitosis, which took
place in a lumen-forming vessel. After nuclear division, cyto-
kinesis displayed EGFP-p20 at the contractile ring, which is in
accordance with the appearance of ARP2/3 complex in dividing
yeast34. After cytokinesis, elongated daughter cells showed EGFP-
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p20 accumulation at their poles opposite to the plane of division,
suggesting formation of large JAIL at these sites (Supplementary
Movie 18). Consistent with this, immune labelling conﬁrmed
large VE-cadherin plaques and actin networks at the cell poles,
whereas small VE-cadherin plaques and actin networks were
displayed at the lateral junctions (Fig. 9f). The impact of the
ARP2/3 complex was also investigated in a Matrigel angiogenesis
assay using the ARP2/3 complex inhibitors CK548 and CK666;
these inhibitors completely blocked the formation of tube-like
structures, whereas the inactive analogues CK312 or CK689 had
no effect (Supplementary Fig. 8). Furthermore, removing the
active inhibitor CK548 re-established the formation of tubule
structures (Supplementary Fig. 8). The data demonstrate that the
ARP2/3 complex is essential for tubule formation.
Inhibition of Notch signalling-induced cell elongation.
VEGFR2 signalling and the Notch pathway control each other
during angiogenesis35,36. Pharmacological inhibition of Notch by
administration of the γ–secretase inhibitor DAPT led to increased
sprouting angiogenesis in wild-type mice (Supplementary
Fig. 9a), as previously described37, with increased perimeter of
ECs in the sprouts (Supplementary Fig. 9b). These data were
conﬁrmed in endothelial-speciﬁc DLL4 knockout mice that also
displayed upregulated angiogenesis (Supplementary Fig. 9c);
however, the total amount of VE-cadherin remained constant
upon inhibition of Notch signalling, as veriﬁed by RT-PCR
(Supplementary Fig. 9d). The results are in accordance with the
observation that a deletion of Rbpj, coding for a principal tran-
scriptional effector of Notch signalling, increases EC size in
mouse retinas38. Application of DAPT to HUVEC cultures
caused cell elongation (Supplementary Fig. 10a, b), increased the
cell perimeter, and decreased the Rel-VEcad-C (Supplementary
Fig. 10c, d), which was accompanied by a decrease in barrier
function due to cell elongation (Supplementary Fig. 10e). DAPT
application did not change the expression of cell adhesion
molecules (Supplementary Fig. 10f, g) but downregulated Hes-1
and DLL4, which conﬁrms the DAPT inhibitory activity (Sup-
plementary Fig. 10h). Furthermore, cell migration increased in a
scratch assay of HUVEC cultures (Supplementary Fig. 10i, j).
Taken together, these data provide additional evidence that cell
elongation is a critical parameter for determining Rel-VEcad-C
and migration activity.
Discussion
Our data document cell elongation is required for initiation and
maintenance of polarized cell migration during angiogenesis. We
showed that the elongation of polygonal cells in conﬂuent cultures
leads to an increase in the cell contact length and to a reduced Rel-
VEcad-C. In contrast the total VE-cadherin concentration remains
unchanged as veriﬁed in ECs of vessel sprouts in wt and in DAPT-
treated mice in vivo. These data are in agreement with VE-
cadherin-dependent stalk cell elongation in zebraﬁsh39, and with
an unchanged VE-cadherin expression in growing and conﬂuent
HUVEC cultures8,40, an unchanged VE-cadherin mRNA expres-
sion, and an increase in cell size or cell elongation in angiogenesis,
as shown in vivo and in vitro38,39,41,42.
The here presented data could explain why a moderate VE-
cadherin depletion increases sprouting in vitro6 and in the
murine retina in vivo3. In contrast to VEGF, which does not
change VE-cadherin expression, elongated arterial ECs and shear
stress-exposed EC have an upregulated VE-cadherin expression
that compensates for the increase in cell junction length43. In
addition, ablation of the Cdh5 gene in mouse embryos alters
vessel growth and lumen formation7,44. Taken together, the data
indicate a balanced VE-cadherin concentration at the cell con-
tacts is decisive for induction and progression of angiogenesis. A
decrease in Rel-VEcad-C is a stimulus for actin-mediated JAIL
formation under the guidance of the WAVE/WASP/ARP2/3
complex, since a carboxyl-terminal VE-cadherin deletion mutant
results in increased JAIL formation8, whereas VE-cadherin
overexpression blocks JAIL formation, VEGF-induced cell elon-
gation, and cell migration. We propose that the different VE-
cadherin patterns, particularly noticeable in the VEGF-induced
elongated cells, are a critical subcellular determinant of polar cell
migration. We suggest that the Rac-dependent formation of large
JAIL, appearing at the cell poles with an interrupted VE-cadherin
pattern, drives the forward-directed migration, whereas small
JAIL at the lateral cell junctions that form a linear VE-cadherin
pattern allow the relative movement of adjacent cells. This is
different from highly dynamic subconﬂuent cultures, which also
have large cell perimeters but show a heterogeneous VE-cadherin
pattern and a randomised JAIL formation and cell migration,
indicating the importance of the elongated cell shape for polar-
ized cell migration. In ﬁsh embryos, a transient shape change has
been attributed to arteriogenesis45 and seems to be related to
Notch controlled CXCR4 expression46 that in turn was shown to
control VE-cadherin expression47. Importantly, blood ﬂow
induces inverse blebs at the apical EC membrane that drives
lumen formation48 and might involve JAIL dynamics, a basal-to-
apical VE-cadherin ﬂow49, an actomyosin ﬂow50, and force
development of protrusions51 may also play a role.
The VEGF-induced cell elongation is dependent on a high
VEGFR2 expression, which occurs only in a subpopulation in
HUVEC cultures and thus could explain the heterogeneous cell
Fig. 5 VEGF-induced shape change is accompanied by dephosphorylation of myosin II light chain at the junction. a LSM of VE-cadherin and VEGFR2 in
HUVECs treated with 50 ngml−1 VEGF or PBS. VEGF-induced invaginations (arrows) were mostly found in cells with high VEGFR2 intensity (stars) but not
in less VEGFR2-expressing cells (crosses). b SIM of VE-cadherin- and Phalloidin-TRITC-labelled HUVECs after VEGF demonstrates that VE-cadherin
invaginations largely co-localise with actin ﬁlaments (arrows). VE-cadherin and actin at cell junctions (arrowheads). c LSM of phospho (ser19)-myosin II
light chain (P-ser-MII-LC) and VE-cadherin in P6 mice retina. P-ser-MII-LC was largely seen in the junction of centre vein but not in front ECs. d HUVECs
treated with 50 ngml−1 VEGF and 10 µM Y27632, respectively, were immune labelled with P-ser-MII-LC and Phalloidin-TRITC. VEGF induced a partial loss
of P-ser-MII-LC at junctions accompanied by a partial loss of JAAF (arrowhead) and wave-like junction remodelling. Stress ﬁbres (open arrowheads) were
P-ser-MII-LC positive. Arrows indicates intact JAAF. Y27632 treatment caused a total loss of P-ser-MII-LC and also induced wave-like junction
remodelling. Quantiﬁcation of e number (n= 411 VE-cadherin invagination for 305 cells for PBS, 815 VE-cadherin invaginations for 338 cells for VEGF) and
f length of VE-cadherin invaginations in VEGF- (n= 98 VE-cadherin invaginations) and PBS-treated (n= 92 VE-cadherin invagination) cells. Quantiﬁcation
of (g) VE-cadherin-positive invaginations (n= 422 and 280 VE-cadherin invaginations for 143 Y27632 and DMSO treated cells respectively), (h)
invagination length (n= 227 and 232 VE-cadherin invaginations for Y27632 and DMSO separately), (i) cell perimeter, and j Rel-VEcad-C in Y27632-
treated cells for 1 h or DMSO based on VE-cadherin immune labelling (n= 143 cells); (compare Supplementary Fig. 5b). Unpaired student’s t test was used
for (e–j). k, l HUVECs pre-treated with 10 µM Y27632 for 1 h were applied with VEGF for another 18 h. Quantiﬁcation of (k) migration velocity (n= 100
cells) and (i) elongation factor (87, 97, 87 and 87 cells were used for Y27632+VEGF, Y27632, VEGF, and control, respectively) using Fiji (compare
Supplementary Fig. 5c); one-way ANOVA. Y= Y27632. Error bars indicate± SEM. Scale bars represent 30 µm in a, c, d and 5 µm in b
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elongation after VEGF stimulation. These data are in line with
results of recent studies that suggest a salt-and-pepper pattern of
VEGFR2 expression in sprouting ECs52,53. VEGF-mediated sig-
nalling appears to induce a polarized modulation of cell junctions
to induce polarized JAIL formation and thus cell elongation. In
particular, we showed that MLC dephosphorylation triggers the
dissociation of JAAFs, and that VEGF treatment or ROCK
inhibition results in the formation of VE-Cadherin-positive
invaginations. These invaginations might dilute the Rel-VEcad-
C locally and thus allow JAIL formation, leading to cell elongation
and directed cell migration. Recent work performed in ﬁsh
embryos indicated that actin polymerisation rather than con-
traction mediates stalk cell elongation, while application of con-
traction inhibitors caused defects in VE-cadherin and
disorganised actin39. These junctional defects are comparable to
both the VEGF-induced VE-cadherin remodelling and after
inhibition of ROCK, which we here identiﬁed as a stimulus for
cell elongation due to JAIL formation. This mechanism might
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also account for shape change during arteriogenesis46. In some
cases, we observed that vesicle-like structures were pinched off
from invaginations but were not further processed in a classical
degradation process (Rab5 and EEA1 negative). VEGF was pro-
posed to cause rapid VEGFR2 turnover and induce signalling for
tip cell formation as well as VE-cadherin endocytosis53,54,
but this process does not appear to account for a signiﬁcant
decrease in Rel-VEcad-C. However, previous work55 and this
study demonstrated VEGF-induced VE-cadherin invaginations
that might behave differently in biochemical and endocytic
pathways.
Both cell polarisation and migration require polarized and
constitutive MT dynamics, as application of nocodazol not only
blocks VEGF-induced cell elongation and directed migration but
also converts elongated cells into polygonal ones. VEGF-induced
cell elongation and increased MT activity occur preferentially at
the MTOC-localised cell half, indicating a critical role of MT and
MTOC in initiation and maintenance of cell polarisation in the
endothelium; these results are in agreement with previous reports
(for review see24,56). In addition, Rac activity is critical for the
induction and maintenance of VEGF-induced cell elongation and
migration, during which a MT-dependent delivery of Rac to the
site of action might take place23,27,28,57. In addition, depletion of
α-parvin, an actin-binding protein, inhibits Rac activity58, which
is in turn a potent activator of JAIL and angiogenesis59.
Directed cell migration occurs at the leading cell pole, which
mostly has an interrupted VE-cadherin pattern, and induces the
formation of large JAIL. As a result of JAIL formation, extensive
VE-cadherin plaques are formed, which can act as adhesion
anchors and allow the forward migration of the cell. The stress
ﬁbres at the leading edge support the directed migration by
contraction, a process recently described in detail15. Although
ﬁlopodia were frequently seen in angiogenesis, as described33,
they could not be blocked by ARP2/3 complex inhibition and
might, therefore, have more of a sensory function1. Furthermore,
ﬁlopodia were recently suggested to be an intermediate phase of
VE-cadherin-mediated cell contact formation60, which is in
agreement with the JAIL-mediated VE-cadherin dynamics. The
junctional regulation by JAIL and the MTOC-dependent cell
polarisation described here may also explain the backward
migration of cells, as observed in cell culture models and in
zebraﬁsh in vivo2. Furthermore, JAIL formation is an iterative
process as long as the local VE-cadherin concentrations are below
a threshold level, and JAIL formation declines if the VE-cadherin
concentration increases. Thus, JAIL formation and shape change
might also signiﬁcantly contribute to vessel extension, lumen
formation, and termination of angiogenesis. We assume that the
relaxation mediated cell elongation is a relatively simple and for
the cell energy-saving possibility to increase the junction
dynamics and thus allows migration activity. The concept of cell
contact regulation in angiogenesis presented here describes a
mechanism to control the polarized cell contact dynamics and cell
migration. (Fig. 10).
Methods
Reagents. Recombinant VEGF165 (VEGF) was obtained from R&D Systems
(#293-VE-010 Wiesbaden-Nordenstadt, Germany) and diluted in phosphate-
buffered saline (PBS) containing 0.1% bovine serum albumin (BSA). The Rac
inhibitor (EHT1864) and microtubule polymerisation inhibitor (nocodazole) were
obtained from Santa Cruz Biotechnology (#sc-361175, Heidelberg, Germany) and
Sigma (#M1404, Munich, Germany), respectively. Sphingosine-1-phosphate 1
receptor (S1PR1) activator (Sew2871) was provided by Abcam (#ab120983,
Cambridge, UK). The γ–secretase inhibitor (GSI-IX, LY-374973, N-[N-(3,5-
diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, DAPT, #565770), and
the ARP2/3 complex inactive inhibitors CK312 (#182518) and CK689 (#182517)
and active inhibitor CK666 (#182515) were purchased from Calbiochem (Bad
Soden, Germany), and the active inhibitor CK548 was purchased from ChemDiv
(#K205-1650, San Diego, USA). Regents were used at concentrations as indicated
in the text.
Cell culture. Human umbilical vein ECs (HUVECs) were isolated from umbilical
cord veins of different donors, a procedure that was approved by the ethics
committee of the WWU- Muenster at the request of the Institute of Anatomy and
Vascular Biology (2009-537-f-S). Umbilical cords veins were perfused with PBS
(#21600069, Thermo Fisher Scientiﬁc, Waltham, MA, USA) followed by digestion
with 1 mgml−1 Collagenase (#C2-22, Biochrom, Berlin, Germany) diluted in PBS
for 10 min at 37 °C in a water bath. The detached cells were collected and cen-
trifuged at 200 × g. Cell were cultured in Endothelial growth medium (PromoCell,
Heidelberg, Germany) supplemented with Endothelial Cell Growth Medium
Supplement Mix and 1% penicillin/streptomycin (P/S) on gelatin-coated tissue
plates or crosslinking gelatin-coated glass cover slips61. CCL-110 cells, HEK 293T,
and HEK 293 cells were purchased from American Type Culture Collection and
cultured in high glucose Dulbecco’s MEM (DMEM) supplemented with 10% FCS,
1% P/S and 1% sodium pyruvate (CCL-110 cells) or 1% Glutamine, respectively.
Coatings of culture dishes with cross-linked gelatin. Culture dishes or glass
bottom dishes were coated with 0.5% gelatin for 1 h at RT, and subsequently
exposed to 2.5% glutaraldehyde/PBS for 10 min at RT. After the solution was
removed, 70% ethanol/H2O was added for 30 min, and subsequently washing with
PBS for 5 times. Active aldehyde groups were neutralised using 2 mM Glycine/PBS
overnight. Prior to cell seeding culture dishes were washed 4 times with PBS.
DNA constructs, viral transductions, and siRNA transfection. Recombinant
lentiviral vectors carrying EGFP-p20, LifeAct-EGFP, VE-cadherin-mCherry and
VE-cadherin-EGFP have previously been used8. β5-tubulin-EGFP62 was kindly
provided by Beat A. Imhof and ampliﬁed using primes 5′-
CTTGGGCTGCAGGTCGACTCTAGAGGATCCATGAGGGAAATCGTGCAC-
3′ and 5′-TTGATTATCGATAAGCTTGATATCGAATTCTTACTTGTA-
CAGCTCGTC-3′, subcloned into pFUGW vector using BamHI and EcoRI
restriction sites. Raichu-Rac130 was ampliﬁed with the primers 5′-TGCAGGTC-
GACTCTAGAGTGGCAAGAATTCGGCATG-3′ and 5′-TCGATAAGCTTGA-
TATCGTTACAACAGCAGGCATTTTC-3′ and subcloned into a PFUGW vector
using BamHI and EcoRI restriction sites.
Lentivirus production. Lentivirus particles were generated in 293T cells cultured
in DMEM (high glucose) medium in 15-cm cell culture dishes. Cells were trans-
fected with the pFUGW vector carrying the gene of interest, the packaging vectors
(pCMV-ΔR8.74), and the VSV glycoprotein-carrying vector (pMD2G,). In parti-
cular, the plasmids pFUGW-gene of interest (23 µg), pCMV-ΔR8.74 (23 µg), and
pMD2G (11.5 µg)] were dissolved in 1.725 ml DMEM medium w/o FCS and
antibiotics (DMEM−/−). The transfection solution, consisting of 124.2 µl of the
Fig. 6 Microtubules (MT) are indispensable for VEGF-induced cell elongation. a Conﬂuent HUVECs immune labelled for VE-cadherin, α-tubulin and
Phalloidin-TRITC after VEGF treatment for 24 h or PBS for control, as indicated. Nuclei are stained blue with DAPI. LSM demonstrates MT in control cells
evenly distributed throughout the cells, while a few MT are aligned in parallel with JAAF (red arrows). VEGF-induced elongated cells display MT running
parallel to the longitudinal cell axis together with stress ﬁbres, and MT are enriched at the leading edge (white arrows; for dynamics compare
supplementary Movie 10) (Scale bar: 20 µm). The cropped area displays an interrupted VE-cadherin pattern, MT enrichment, and stress ﬁbres at the cell
poles (arrowheads; for dynamics compare Supplementary Movies 10 and 11) (scale bar: 10 µm). b Conﬂuent HUVEC cultures treated with 50 ngml−1
nocodazole for 4 h and subsequently labelled with VE-cadherin antibody and with Phallodin-TRITC for actin ﬁlaments. MT depolymerisation had less effect
on the JAAF and VE-cadherin distribution (Scale bar: 20 µm). c–e Conﬂuent HUVECs pre-treated with 50 ngml−1 nocodazole for 30min and then treated
with VEGF for another 18 h. c Phase-contrast microscopy revealed that nocodazole inhibited VEGF-induced cell elongation (scale bar: 80 µm).
Quantiﬁcation of (d) cell velocity and (e) cell elongation using Fiji software (100 cells were analysed at t= 0, 100 cells at t= 9 h, 81 cells at t= 18 h for
nocodazole+VEGF treatment; and 100 cells were analysed at each time point for VEGF treatment, unpaired student’s t test). noco: nocodazole.
Representative results from three independent experiments are shown. Error bars indicate± SEM
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transfection reagent PEI (1 mgml−1) was dissolved in 1600.8 µl DMEM−/− and
incubated at RT for 20 min; it was subsequently added to the plasmid mixture, and
drop-wise added to the 293T cells. After 14–16 h of incubation, a medium
exchange was performed using 20 ml fresh, pre-warmed full DMEM medium. After
24 h of culturing the medium was collected and cleared at 3000 r.p.m. for 10 min.
The supernatant was ﬁltered through 0.45-µm ﬁlters, and the virus was
concentrated by ultracentrifugation (1.5 h at 25,000 r.p.m.; 4 °C). The pellet was
resuspended in 150 µl PBS containing 1% BSA, and aliquots were stored at −80 °C
until use.
Adenovirus ampliﬁcation. Adenovirus carrying VE-cadherin-EGFP, EGFP and
N17Rac1, kindly provided by Masatoshi Takeichi49 and Beata Wojciak-Stothard63,
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respectively, were ampliﬁed by the following steps. HEK 293 cells were seeded in
T75 cm2 tissue culture ﬂasks and cultured for 24 h when reached 80–90% con-
ﬂuency. Medium was changed to DMEM containing w/o FCS and P/S supple-
mented with 1% Glutamine and 10 µl (15 MOL) of stock adenovirus. After
incubation for 1 h, equivalent volumes of DMEM supplemented with 4% FCS, 1%
Glutamine was added to reach a ﬁnal concentration of 2% FCS in culture medium.
After 2 additional days of culturing, four cycles of freeze-thaw-vortex was per-
formed to release the virus. Depending on the amount of virus required, the virus
yield can be signiﬁcantly increased by two or more further culture cycles. For this
purpose, the respective suspension is distributed to 5 times or 10 times greater
HEK293 cell culture area (80–90% conﬂuence), cultured for two days and pro-
cessed by another four cycles of freeze-thaw-vortex. For virus puriﬁcation, the cells
were scrapped from the substrate and spinned down at 500 × g for 10 min, and the
cell pellet was resuspended in 6 ml sterile PBS followed by another for four cycles of
freeze-thaw-vortex. The lysate was cleared by 4000 x g at 4 °C for 20 min. For
further puriﬁcation 6 ml of the supernatant was mixed with 3,3 gr ultrapure CsCl,
vortexed and separated at 1,76 × 105 × g at 10 °C for 22 h. Afterwards, the virus
fraction was collected with glycerol (10% ﬁnal concentration), dialysed against BSS,
aliquoted and stored at −80 °C until use.
Lentivirus- and adenovirus-mediated gene transductions. HUVEC were
transduced by lenti or adenoviruses by incubating the cells with viral particles
suspended in endothelial growth medium w/o FCS and P/S but containing 3%
poly-vinyl-pyrrolidone for 1 h to increase transduction efﬁciency. Cells were fur-
ther cultured and subjected to the experiments after 24–72 h. Expression of the
protein of interest was evaluated by immune ﬂuorescence and Western blotting,
respectively.
siRNA-mediated downregulation of VEGFR2 and Nrp1 in HUVEC. The
VEGFR2 and Nrp1 siRNAs were obtained as on-target plus smart pools from
Dharmacon (Lafayette, CO, USA). Non-targeting siRNAs were purchased as on-
target plus individual siRNAs from Dharmacon. A total of 25–100 nM of speciﬁc or
control siRNA was introduced into the cells using the MATra-siRNA reagent
(#PK-CT-2021-020) and a magnet plate (#PK-CT-2011-000) according to the
manufacturer’s recommendations (Promokine, Heidelberg, Germany). Cells were
used for experiments at 24–72 h after transfection.
Western blot analysis. Cells were lysed in SDS sample buffer (0.18 M Tris, 6%
SDS, 30% glycerine, 80 mg l−1 Bromophenol Blue, 10 mM DTT). The protein
concentration in SDS containing sample buffer was determined by Amido-black
protein assay64. In particular, equal amounts of protein were separated by 8–10%
polyacrylamide gel electrophoresis, wet transferred to a PVDF membrane. The
membrane was incubated with goat anti-VE-cadherin (1:500, #SC-6458, Santa
Cruz Biotechnology, Heidelberg, Germany), rabbit anti-VEGFR2 (1:1000, #2479L,
Cell Signalling Technology, Beverly, MA, USA), rabbit anti-Nrp1 (1:1000, #3725S,
Cell Signalling Technology, Beverly, MA, USA), mouse anti-α-tubulin (1:5000,
#T5168, Sigma, Munich, Germany), mouse anti-γ-catenin (1:1000, #610254, BD
Biosciences, San Jose, CA, USA), mouse anti-N-cadherin (1:1000, #610920, BD
Biosciences, Heidelberg, Germany), and mouse anti-EGFP (1:2500, #632569,
Clontech, California, USA) at 4°C overnight, followed by incubation with IRDye
600 CW and 800 CW infra-red secondary anti-mouse, -goat, and -rabbit antibodies
(1:10000, LI-COR Biotechnology, Bad Homburg, Germany). Immune reactive
bands were detected using the LICOR Infra-red reading system according to the
manufacturer’s instructions. Bands were semi-quantitatively analysed using Fiji
image processing software. Uncropped scans of the blots are available in Supple-
mentary Fig. 11.
Staining of cell cultures and tissues. HUVECs were ﬁxed in 2% PFA for 15 min
at RT and washed three times for 5 min each with 1% BSA in PBS followed by mild
permeabilization with 0.1% Triton X-100 (#28314, Thermo Fisher Scientiﬁc,
Waltham, MA, USA) in PBS for 10 min at 4 °C. After three more washes with 1%
BSA in PBS, cells were incubated with goat anti-VE-cadherin (1:50, #SC-6458,
Santa Cruz Biotechnology, Heidelberg, Germany), rabbit anti-γ-catenin (1:50,
#610254, BD Biosciences, Heidelberg, Germany), rabbit anti-EEA1 (1:200, #2411,
Cell Signalling Technology, Beverly, MA), rabbit anti-Rab5 (1:1000, #ab18211,
Abcam, Cambridge, UK), mouse anti-α-tubulin (1:1000, #T5168, sigma, Munich,
Germany), rabbit anti-phospho myosin light chain II (ser19) (1:50, #3671, Cell
Signalling Technology, Beverly, MA), and rabbit anti-VEGFR2 (1:200, #2479L, Cell
Signalling Technology, Beverly, MA), overnight at 4 °C. Following 4 washes, the
appropriate Alexa-Fluor-coupled secondary antibodies (1:200, Invitrogen, Darm-
stadt, Germany), in parallel with Phalloidin-TRITC (1:500, #P1951, Sigma,
Munich, Germany), were added to the samples for 1 h at room temperature. Cells
were rinsed, counterstained with DAPI (#28718-90-3, Sigma, Munich, Germany),
and then mounted in DAKO ﬂuorescent mounting medium (#S3023, Agilent
Technologies, Böblingen, Germany). All animal experiments were carried out with
the approval of the local animal ethics committees and performed with permission
of the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen
and in accordance with guidelines for conducting animal experiments in a humane
manner. The approval for mice experiments was granted to Max Planck Institute
for Molecular Biomedicine (Laboratory of Ralf H. Adams), and the approval for
tissue samples taken were granted to the Institute of Anatomy and Vascular
Biology (Laboratory of Hans Schnittler).
For endothelial-speciﬁc loss-of-function of Dll4, we interbred Pdgfb-iCre T/+
transgenic mice65 and Dll4 loxlox mice66. Mice of both genders (1:1 ratio) were
provided by the animal facility at the Max Planck Institute of Molecular
Biomedicine (Münster, Germany). Pups obtained from mating of Dll4 loxlox and
Pdgfb-iCre T/+ Dll4 loxlox mice were injected from P1 to P3 with 50 µg tamoxifen
and further analysed at P6. Dll4 iΔEC mutant pups (Cre+) were compared to control
(Cre-) littermates. For treatment of P5 C57BL/6 mice, provided by the animal
facility at the Max Planck Institute of Molecular Biomedicine (Münster, Germany),
of both genders (1:1 ratio) DAPT dissolved in 10% absolute ethanol and 90%
peanut oil or vehicle was injected into the stomach of mice according to the body
weight (0.1 mg kg−1 body weight), and this treatment was repeated after 12 h. Pups
were analysed at 24 h from the ﬁrst injection.
For ex vivo investigations, eyes of both genders (1:1 ratio) were collected from
P7 Wistar rats provided by ZTE of University of Münster (Münster, Germany),
from P6 wild-type (WT) mice, from P6 transgenic mice expressing LifeAct-EGFP
in the retina vessels17 provided by the Max Planck Institute of Biochemistry,
Department of Molecular Medicine (Munich, Germany), and from P6 Dll4 iΔEC
and littermate control mice. All eyes and E14.5 yolk sac and mature vena cava from
WT mice were collected and ﬁxed in 4% PFA for 2 h on ice. Samples were
dissected, permeabilized and blocked in PBS containing 1% BSA and 0.3% Triton
X-100 (blocking buffer) at RT for 2 h. Samples were then incubated with goat anti-
VE-cadherin (1:50, #AF1002, R&D Systems, Wiesbaden-Nordenstadt, Germany)
or rabbit anti-ERG (1:100, #ab110639, Abcam, Cambridge, UK), rabbit anti-
phospho myosin light chain II (ser19) (1:50, #3671, Cell Signalling Technology,
Beverly, MA) or rabbit anti-ARPC2 (1:200, #07-227, Merck Millipore, MA, USA)
overnight at 4 °C. After four washing steps, samples were incubated with the
corresponding Alexa-Fluor-coupled secondary antibody in blocking buffer for 2 h
at RT. Samples were washed with washing buffer (0.5% BSA and 0.15% Triton x-
100 in PBS) for 4 times and subsequently mounted in DAKO ﬂuorescent mounting
medium.
Microscopy. For phase-contrast live-cell imaging, cells were placed on a gelatin-
coated 12-well plate, and automatically imaged with an Axio observer Z1 (Carl
Fig. 7 Junction dynamics upon VEGF treatment in conﬂuent HUVECs. HUVECs expressing (a) VE-cadherin-EGFP (b–e) LifeAct-EGFP or (f–g) EGFP-p20,
respectively, were treated with 50 ngml−1 VEGF. a (upper) Controls display regular VE-cadherin-EGFP dynamics with VE-cadherin plaques (white arrows)
due to JAIL formation. (middle) After VEGF treatment, elongated cells exhibit a polar distribution with an interrupted VE-cadherin pattern at cell poles (red
arrowheads) followed by transient formation of new large VE-cadherin plaques (dotted lines). (lower) Lateral junctions display linear VE-cadherin pattern
with appearance of small VE-cadherin plaques (white arrows). Small VE-cadherin interruptions (red arrows) appear transiently. Time scale: mm:ss; scale
bars indicate 10 and 5 µm in the overview and cropped images. b LifeAct-EGFP dynamics after VEGF. (upper) The overview images demonstrate both
polygonal cells and elongated cells (white arrows) (scale bar: 30 µm). (Area 1) Polygonal cells display constitutive junction remodelling that includes the
transient appearance of small stress ﬁbres (red arrows) and small JAIL (white arrowheads) without signiﬁcant cell elongation. (Area 2) A progressively
moving elongated cell exhibits many ﬁlopodia (empty arrowheads) that appear on the sides of large JAIL (white arrowheads). Note: stress ﬁbres (red
arrows) preferentially emerge at the leading edge of the cells. Time scale: hh:mm; scale bar: 10 µm. c, d JAIL and ﬁlopodia number in polygonal and
elongated cells in VEGF-treated culture. e Track plots illustrate migration path of elongated cells (black line) and polygonal cells (red line). f Small JAIL
formation at the lateral junctions (cropped area 1, arrowheads) and large JAIL development at the cell poles (cropped area 2, arrowheads) in VEGF-induced
elongated ECs expressing EGFP-p20. The dotted line indicates the cell border; arrow indicates the direction of cell movement. Time scale, mm:ss; scale bar
represent 20 and 10 µm in overview and cropped images. g JAIL size at the cell poles and the lateral sides of elongated cells induced by VEGF. 157 JAIL at
the cell pole and 152 JAIL at the lateral junctions from three independent experiments were analysed over a period of time (30min). Unpaired student’s t
test was used for statistics analysis and error bars indicate± SEM
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Fig. 8 Polarized Rac activity is required for VEGF-induced cell elongation and migration. a–c Conﬂuent HUVECs expressing FRET sensor Raichu-Rac1 were
treated with VEGF for 24 h. a Representative images showing different levels of Rac1 activity within control cells and VEGF-induced elongated cells. Control
cells displayed less and randomised Rac1 activity (arrowhead; compare Supplementary Movie 13). Polarized, higher Rac1 activity is observed at the leading
front (arrow indicates migration direction; compare Supplementary Movie 13). Small foci of elevated Rac activities are observed at the lateral side
(arrowheads); scale bars: 20 µm. b Plot of ﬂuorescence intensity along the line is indicated. c Quantiﬁcation of overall Rac1 activity as deﬁned by the ratio of
YFP/CFP in PBS- or VEGF-treated cells (n= 74 and 87 cells were analysed from 4 independent experiments for PBS and VEGF, respectively (unpaired
student’s t test)). d, e Conﬂuent HUVECs pre-treated with EHT1864 for 30min were treated with VEGF for additional 19 h. Quantiﬁcation of (d) elongation
factor and (e) migration velocity after EHT1864 + VEGF (n= 100 cells) and VEGF (n= 101 cells) treatment for the time period of 19 h (unpaired student’s t
test). f Conﬂuent HUVEC cultures expressing adeno-N17Rac1 display decreased VEGF-induced cell elongation as determined by PhaCoB Cell Tracker (n≈
1000cells/time point). g–h Sew2871 application upregulated VEGF-induced cell elongation and migration ability. g Time-lapse recordings of conﬂuent
HUVECs expressing EGFP-p20 treated with 10 µM Sew2871. Sew2871 largely increased JAIL formation (arrowheads). Time scale: hh:mm; scale bars: 10
µm. h Quantiﬁcation of overall EGFP-p20 intensity upon Sew2871 application. i, j Conﬂuent HUVEC cultures were pre-treated with 10 µM Sew2871 for 1 h
before 50 ngml−1 VEGF was applied. i Quantiﬁcation of elongation factor over time, as indicated (data are based on the analyses of 173, 162, 164, 173 cells
for t= 0, 6, 12 and 18 h, respectively). j Comparison of migration velocity after Sew2871+VEGF, Sew2871, VEGF and control treatments, respectively, for 16
h (data are based on analyses of 103, 102, 99 and 100 cells for each group). One-way ANOVA was used to analyse signiﬁcance difference for i, j.
Representative results from three independent experiments are shown. Error bars represent± SEM
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Zeiss, Oberkochen, Germany) supplied with humidity and 5% CO2 using an LDA-
plan 10× or 20× objective lens.
For ﬂuorescence live-cell imaging, cells were seeded on crosslinking gelatin-
coated custom-made 35 mm glass-bottomed dishes. Time-lapse recordings were
performed using a spinning-disc confocal microscope (SDM), (Carl Zeiss,
Oberkochen, Germany) equipped with deﬁnite focus and a heated stage that
ensures humidity and 5% CO2. Live cells were imaged either using an Apo 1.3 oil
40× or alpha Plan Apo 1.46 oil 63× objective and the appropriate lasers for
excitation and emission.
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Structural illumination microscopy (SIM) was carried out using a Zeiss Elyra/
LSM 780 microscope. The SIM images were acquired using a 100× or 63× plan-
Apochromat oil-immersion objective and an electron-multiplying CCD camera
with the use of 405, 488, 563, and 647 nm diode lasers. Images were reconstructed
and processed for structure illumination with Zen imaging software (Carl Zeiss,
Oberkochen, Germany). The alignment parameters for the different channels were
obtained from measurements of a multispec calibration slide (170 nm multi-
wavelength ﬂuorescent beads, Carl Zeiss) taken with the same camera setup as the
biological samples.
Automated cell tracking using phase-contrast images. A novel software, the
phase contrast based (PhaCoB) cell tracker, was created to analyse morphody-
namic parameters of phase-contrast time-lapse sequences. The automated cell
tracking of phase-contrast images of EC cultures is based on a combination of two
probabilistic models. Firstly, a Markov Random Field model for binary valued
segmentations with higher-order Pn-Potts potentials67,68 is applied to each image
of the sequence independently to provide foreground probabilities for each pixel in
the image. These probabilities are then used to generate hypotheses for elliptically
shaped foreground blobs that consist of pixels with sufﬁciently high foreground
probability and cannot be enlarged without changing their geometry (up to scale).
Note, that the generated ellipses are not considered to be ﬁnal cell detections at this
step of the approach but rather form a superset of the true cell ellipses, leaving the
ﬁnal decision to subsequent steps of the approach. Secondly, collections of inter-
acting trajectories are modelled by which each trajectory is a temporally contiguous
sequence of ellipses. Trajectories may start and end at any time. The model for a
single trajectory is a Markov chain model incorporating a motion model, e.g., a
“constant velocity” model, as well as the assumption of “continuous” changes of the
cell shape. The interaction between the trajectories reﬂects the assumption that the
cells in the conﬂuent layer do not overlap each other. The resulting joint prob-
abilistic model favours large and consistent collections of trajectories composed
from the cell candidates found in the previous step of the approach. Algor-
ithmically, this is achieved by ﬁrst randomly generating such collections from the
model. The ﬁnal decision is obtained by Bayes risk minimisation for an appro-
priately chosen loss function. The second part of the model generalises a previously
published simpler model for collections of point processes69. The number of cells
visible in the frames of time lapse videos varies in time. One reason for this is that
cells can leave or enter the ﬁeld of view. Consequently, we report the average
number of tracked cells in Figs 4l, n and 8f.
In an alternative method, for the images shown in Figs 2k, 5l, 6e and 8i, the cell
border was ﬁrst outlined manually using Fiji software and the elongation factor was
deﬁned by the cell aspect ratio where the length of the major axis is divided by the
minor axis of the ellipse that best ﬁts the object.
Quantiﬁcation of morphology and dynamics. Quantiﬁcation of cell migration
was performed by manual cell tracking using the Fiji ‘Manual Tracking’ plugin
(https://imagej.nih.gov/ij/plugins/track/track.html) and the ‘Chemotaxis and
Migration Tool’. Migration was analysed by comparing parameters, including i)
accumulated distance (the total distance that the cell travelled) and ii) Euclidean
distance (the straight-line distance between the start and end point of cell travel).
For quantiﬁcation of the HUVEC perimeter, images labelled with VE-cadherin
were ﬁrst segmented using our own lab-developed software CellBorderTracker
(CBT)12, and then the perimeter was determined using Fiji. Relative VE-cadherin
concentration (Rel-VEcad-C) in cell cultures was quantiﬁed using CBT software as
described previously12. Rel-VEcad-C was deﬁned by dividing the integrated VE-
cadherin intensity of the region of interest (ROI) by the total cell length of the ROI.
For quantiﬁcation the cell perimeters in mouse retinal ECs, the Z-stack images of
VE-cadherin labelling were assessed and the cell outline was drawn manually. For
the analysis of VE-cadherin intensity in mouse retinal ECs, VE-cadherin immune-
labelled single junctions were selected and subjected to a threshold. The relative
VE-cadherin intensity at the junction was quantiﬁed by dividing the integrated VE-
cadherin intensity by the junction length within the ROI.
Fluorescence resonance energy transfer (FRET) analysis. FRET-based evalua-
tion of Rac activity was carried out 2 days after viral transduction of the FRET
sensor Raichu-Rac-1, HUVECs were stimulated with either 50 ng ml−1 VEGF or
PBS for control. After 24 h YFP and CFP images were recorded by Zeiss Axioplan2
upright microscope (Oberkochen, Germany) and the FRET ratio of YFP/CFP
images were analysed using Fiji software29.
Real-time PCR analysis in cell culture and in vivo retina. Total RNA was
puriﬁed from HUVEC lysates using the GeneMatrix Universal RNA Puriﬁcation
Kit (#E3598-02, EURx, Berlin, Germany) following the manufacturer’s instruc-
tions. Complementary cDNA was synthesised by using 500 ng of RNA with the
Reverse Transcriptase Core Kit (#RT-RTCK-03, Eurogentec, Liege, Belgium)
according to the supplier’s protocol. (RT-PCR) RT-PCR was carried out with the
use of a SYBR Green PCR Master Mix (#07-KK4600-03, KAPA2G Fast Readymix
with Dye, Peqlab, Erlangen, Germany) using the following primers: 5′-
GAGGGTCTCTCTCTTCCTCTTGT-3′ and 5′-CTCCTCTGACTTCAA-
CAGCGACA-3′ for GAPDH; 5′-TCCAACAGTGGGCAGCGAAG-3′ and 5′-
CATAGTAGCCCGGAGGACAC-3′ for DLL4; 5′-GATAGCTCGCGGCATTC-
CAAG-3′ and 5′-CTCAGCGCAGCCGTCATCTG-3′ for Hes-1; 5′-
GAGCCGCCGCCGCAGGAAG-3′ and 5′-CGTGAGCATCCAGCAGTGGTAGC-
3′ for VE-cadherin. The relative quantiﬁcation of the target gene was normalised to
the GAPDH control and calculated using 2−ΔΔCt.
Prior to performing RNA extraction of retina ECs, FACS was applied to sort
retina ECs. Brieﬂy, freshly dissected retinas of Dll4 iΔEC P6 pups and control
littermates were lysed in a collagenase solution for 40 min at 37 °C. The
homogenates were ﬁltered through a 70 µm cell strainer(#352350, Falcon) and
further resuspended in DMEM with 10% FCS. Filtrates were centrifuged for 5 min
at 300 × g and cells were incubated with antibody solution (rat anti-CD31-FITC
(#RM5201, Invitrogen, Darmstadt, Germany) and rat anti-CD45-PE (#553081, BD
Pharmingen, San Jose, CA, USA) for 30 min on ice. After washing, retinal cells
were resuspended in DMEM with 3% FCS and CD31 +/CD45- cells were sorted
using FACS Canto ﬂow cytometer.
RNA extraction from FACS sorted retinal ECs was performed using RNeasy
Plus Micro Kit (#74034, Qiagen, Hilden, Germany). First-strand cDNA was
synthesised using the iScript cDNA synthesis kit (#170-8890, Bio-Rad, Hercules,
CA, USA). RT-PCR was performed using TaqMan Gene Expression Master Mix
(#4369016, ThermoFisher Scientiﬁc, Waltham, MA, USA) along with Taqman
assay for Cdh5 (#Mm00486938_m1, ThermoFisher Scientiﬁc, Waltham, MA, USA)
and for ActB (#4369016, ThermoFisher Scientiﬁc, Waltham, MA, USA), used to
normalise gene expression.
In vitro ﬁbrin gel angiogenesis assay. Fibrin gel angiogenesis assays were carried
out using HUVECs that were seeded onto Cytodex 3 micro-carrier beads (#C-3275,
Sigma, Munich, Germany) at a concentration of ~400 cells per bead for 4 h and
then allowed to adhere overnight. Following overnight culture, the coated beads
were suspended in a 2 mgml−1 ﬁbrinogen solution (#F-8630, Sigma, Munich,
Germany) containing 0.15 units ml−1 of aprotinin (#A-1153, Sigma, Munich,
Germany) and 0.625 units ml−1 of thrombin (#T-4648, Sigma, Munich, Germany)
and plated in custom-made Petri dishes with 1 cm2 glass bottoms. After the
ﬁbrinogen solidiﬁed, 2 ml of EGM-2 medium (#CC-3162, Lonza, Basel, Switzer-
land) containing 10 ng ml−1 of recombinant human VEGF was added. Finally,
CCL-110 cells were seeded on top of the ﬁbrin gel at a concentration of 1 × 104 cells
per well.
Fig. 9 Polarized JAIL dynamics during sprouting angiogenesis in ﬁbrin angiogenesis assay using EGFP-p20 expressing HUVECs. a–c SDM based time-lapse
recordings (TLR) of different cell junctions during sprouting angiogenesis. In the overview of b, c, f, Yellow dotted lines indicate the z-projection level.
Purple dotted line completes the lumen-forming sprouts since not all cell expressed the ﬂuorescence-tagged protein and white dotted line outlines the cell
junctions. a Overview of tip cell sprouts. (cropped area) EGFP-p20-positive plaques identiﬁed transient lamellipodia and ﬁlopodia at the tip cell front
(arrows). b Overview and Z-projection of tip cell/stalk cell junctions. (cropped area) TLR of large JAIL that development at the cell poles (white dotted
lines, area 1) and faint and small JAIL appearing at the lateral junction (arrows, area 2). c JAIL formation between stalk cell/stalk cell junctions. (cropped
area 1) TLR demonstrate large JAIL formation at the cell pole (dotted line). (cropped area 2, middle panel) Small JAIL developed at lateral junction (arrows).
(cropped area 2, lower panel) ARP2/3 complex inhibitor CK666 applied to the same cells blocked JAIL formation. d Quantiﬁcation of JAIL size in the
migrating pole and lateral side of the sprouting ECs. Sixty-four JAIL at the leading cell pole and 45 JAIL at the lateral junctions from 3 movies over a period
of 30min were analysed, unpaired student’s t test. e Inhibition of cell migration ability after ARP2/3 complex inhibitor (CK666) and inactive control
inhibitor (CK689) and Rac inhibitor EHT1864. Quantiﬁcation is based on phase-contrast time-lapse recordings for the time period up to 6 h; n= 67, 70, 82
cells before and 69, 70, 85 cells after CK666, CK689, or EHT1864 treatment, respectively. Cells were pooled from two independent experiments; two-way
ANOVA. f Overview and Z-projections of vessel sprouts in ﬁbrin angiogenesis assays 5 days after seeding; cells were ﬁxed and labelled with Phalloidin-
TRITC and VE-cadherin. (cropped areas) JAIL are indicated at cell poles by the appearance of large VE-cadherin plaques (arrows) that co-localise with the
actin network (arrows), whereas small VE-cadherin plaques appear at lateral junctions (arrowhead). Error bars represent± SEM; scale bars indicate 50 and
10 µm in the overview and cropped areas, respectively
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Endothelial tube formation in Matrigel. A total of 70 µl of Matrigel basement
membrane matrix (#356234, Corning, New York) was added to custom-made Petri
dishes with 1 cm2 glass bottoms and placed in the incubator for 30 min at 37 °C to
allow polymerisation. After that, HUVECs were seeded on top of the Matrigel
matrix at a concentration of 3 × 104 cells per cm2. Two hours after seeding, the
indicated concentrations of the active ARP2/3 inhibitors CK666 (100 µM) or
CK548 (50 µM), in parallel with their inactive controls CK689 (100 µM) and
CK312 (50 µM), were applied to the cells.
Impedance measurements. Impedance measurements were performed using
HUVECs that were seeded in custom-made measuring impedance chambers and
the measurements were initiated when cells reached conﬂuence. The indicated
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Fig. 10 The scheme illustrates the proposed model of the molecular mechanisms driving cell migration in angiogenesis
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concentrations of DAPT were added and the impedance was monitored at 10-min
intervals. From the impedance spectroscopy data, the trans-endothelial electrical
resistance (TER) was determined using TER analytical software (MOS-Technolo-
gies, Telgte, Germany) and was calculated as TER(t)/TER(t = 0), which is the TER
value at a given time point (t) divided by the TER at the time point zero.
Statistics. Statistical analyses were performed using GraphPad Prism 6 software
(GraphPad Software, La Jolla, CA, USA). Comparisons between two groups were
conducted using Student’s t test, and analyses among more than two groups were
performed using one-way ANOVA followed by Tukey’s post hoc test. Two-way
ANOVA was applied to compare the means of two independent variables, followed
by Sidak post hoc test. Differences with P values <0.05 were considered signiﬁcant.
The data are presented as the mean± SEM of at least three independent experiments.
Data availability. All the data will be made available from the authors upon
reasonable request.
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